Back to Results
First PageMeta Content
Eli Lilly and Company / Pioglitazone / Rosiglitazone / Anti-diabetic drugs / Medicine / Anti-diabetic medication / Epidemiology / ADAS / Coronary artery disease / Thiazolidinediones / Pyridines / Health


U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived
Add to Reading List

Open Document

File Size: 576,51 KB

Share Result on Facebook

Company

Cox / John Wiley & Sons / Case / /

Country

United Kingdom / /

IndustryTerm

literature search / /

MedicalCondition

transient ischemic attack / stroke mortality coronary artery disease / congestive heart failure / unstable angina / angina pectoris / cerebrovascular accidents / heart failure / coronary heart disease / acute myocardial infarction / /

Organization

Drug Safety and Risk Management Advisory Committee / Epidemiology office of Surveillance and Epidemiology / Endocrinologic and Metabolic Drugs Advisory Committee / U.S. Food and Drug Administration / M.P.H. Division / /

Person

Yap / Kate Gelperin / Esther Zhou / /

Product

pioglitazone / rosiglitazone / /

TVStation

Koro / /

Technology

CAD / /

SocialTag